1. Home
  2. VSAT vs NVCR Comparison

VSAT vs NVCR Comparison

Compare VSAT & NVCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo ViaSat Inc.

VSAT

ViaSat Inc.

HOLD

Current Price

$77.12

Market Cap

9.6B

Sector

Technology

ML Signal

HOLD

Logo NovoCure Limited

NVCR

NovoCure Limited

HOLD

Current Price

$16.59

Market Cap

2.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
VSAT
NVCR
Founded
1986
2000
Country
United States
Switzerland
Employees
N/A
N/A
Industry
Radio And Television Broadcasting And Communications Equipment
Medical/Dental Instruments
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
9.6B
2.0B
IPO Year
1996
2015

Fundamental Metrics

Financial Performance
Metric
VSAT
NVCR
Price
$77.12
$16.59
Analyst Decision
Strong Buy
Buy
Analyst Count
6
6
Target Price
$59.80
$28.08
AVG Volume (30 Days)
1.4M
968.8K
Earning Date
05-19-2026
04-30-2026
Dividend Yield
N/A
N/A
EPS Growth
94.42
21.79
EPS
N/A
N/A
Revenue
N/A
$655,353,000.00
Revenue This Year
$5.32
$7.72
Revenue Next Year
$3.57
$6.74
P/E Ratio
N/A
N/A
Revenue Growth
N/A
8.28
52 Week Low
$26.10
$9.82
52 Week High
$93.03
$21.45

Technical Indicators

Market Signals
Indicator
VSAT
NVCR
Relative Strength Index (RSI) 53.24 49.68
Support Level $66.99 $16.33
Resistance Level $75.57 $18.43
Average True Range (ATR) 3.78 0.75
MACD 0.31 -0.07
Stochastic Oscillator 69.57 46.42

Price Performance

Historical Comparison
VSAT
NVCR

About VSAT ViaSat Inc.

Viasat Inc an world-wide provider of communications technologies and services, focused on making connectivity accessible, available and secure for current and future customers world-wide. The company has two reportable segments: communication services and defense and advanced technologies. It generates majority of revenue from communication services segment provides a wide range of broadband and narrowband communications solutions across government and commercial mobility markets, as well as for residential and enterprise fixed broadband customers. It has presence in United States and Outside United States. The company generates majority of revenue from United States. Its products are Antennas, Terminals & radios, Modems, Semiconductors, Cybersecurity, Software & services, Home internet.

About NVCR NovoCure Limited

NovoCure Ltd is an oncology company with a proprietary platform technology in the United States. Its business involves the development, manufacture, and commercialization of Tumor Treating Fields (TTFields) devices, including Optune Gio and Optune Lua, for the treatment of solid tumor cancers. Its pipeline consists of Trident, Lunar-2, Panova-3, Metis, and other products and technologies for the treatment of Glioblastoma, Non-small cell lung cancer, and Pancreatic cancer. Geographically, the company derives the majority of its revenue from the United States and the rest from Germany, Japan, and other markets.

Share on Social Networks: